Veronique Eder

2 Bis Boulevard Tonnellé
Tours, 37000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Author Correction: Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Author Correction: Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Journal: Scientific reports

Published: April 13, 2018

Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Journal: Scientific reports

Published: January 23, 2017

USPIO size control through microwave nonaqueous sol-gel method for neoangiogenesis T2 MRI contrast agent.

USPIO size control through microwave nonaqueous sol-gel method for neoangiogenesis T2 MRI contrast agent.

Journal: Nanomedicine (London, England)

Published: October 15, 2016

FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.

FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 02, 2015

F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study.

F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study.

Journal: Joint bone spine

Published: August 21, 2014

Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.

Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.

Journal: Radiology

Published: April 26, 2014

Current applications of PET/CT

Current applications of PET/CT

Journal: La Revue du praticien

Published: January 16, 2014

Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.

Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.

Journal: PloS one

Published: October 02, 2013

FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review.

FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review.

Journal: Autoimmunity reviews

Published: September 18, 2013

Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphoma.

Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphoma.

Journal: Acta haematologica

Published: June 11, 2013

18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome.

18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome.

Journal: Autoimmunity reviews

Published: June 01, 2013

Use of hybrid SPECT/CT for diagnosis of radiographic occult fractures of the wrist.

Use of hybrid SPECT/CT for diagnosis of radiographic occult fractures of the wrist.

Journal: Clinical nuclear medicine

Published: February 05, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026